GLP-1 medications have quickly become some of the most talked-about treatments in weight loss and metabolic health, but for many people, the first question is still the most basic one: what is a GLP-1, exactly?
These weight loss medications are designed to mimic a natural hormone that helps regulate appetite, digestion, and blood sugar, which is why they can help some people feel fuller sooner, eat less, and improve certain metabolic markers over time. As their popularity has grown, so has the confusion around what they actually do, who they may be right for, and what the experience of taking one is really like.
Understanding how GLP-1s work, the different options available, and what to expect when starting treatment can help you make a more informed decision about whether this type of medication may be a good fit for you.
Types of GLP-1s for Weight Loss
There are a few different types of GLP-1-related medications available, and the main difference comes down to how they work and how they are taken.
Semaglutide is a GLP-1 medication available in FDA-labeled injectable and oral products, although the specific indication depends on the product.
Tirzepatide (Mounjaro / Zepbound), by contrast, is a dual incretin medication that targets both GIP and GLP-1 receptors, giving it an additional pathway beyond GLP-1 alone, and it is FDA-labeled as a weekly injection.
Both medications can help lower appetite, improve blood sugar, and slow down digestion, which can help people feel full sooner but can also cause stomach-related side effects like nausea or constipation. The simplest way to think about it is that semaglutide works on one of the body's appetite and blood sugar signals, while tirzepatide works on two. Both can be effective, but research has shown that tirzepatide has led to greater average weight loss than semaglutide in some head-to-head studies.
Who May Be a Candidate for Weight-Loss Medication and Which GLP-1 May Be the Right Fit?
GLP-1 medications and other anti-obesity treatments can be a helpful option for some people, but they are not the right choice for everyone. Whether someone may be a good candidate depends on a clinician's assessment of their medical history, current medications, weight-related health conditions, lifestyle, likely benefits, possible side effects, family history, and cost. These medications are generally used to support people whose weight is affecting their health, and they are most effective when paired with a broader treatment plan that includes nutrition, movement, and behavior support rather than used on their own.
For those who may qualify, the best medication depends on the individual. Tirzepatide may be a strong option for someone seeking the greatest average weight-loss results, since it works on two hormone pathways instead of one. Semaglutide may be a better fit for someone who wants more formulation flexibility, since semaglutide is available in FDA-labeled injectable and oral products, while tirzepatide is FDA-labeled as a weekly injection. A clinician may also consider how someone tolerates digestive side effects, what other medications they take, and whether they have other health conditions such as diabetes or heart disease. In the end, the right option is not always the newest or most powerful one, but the one that is safest, most sustainable, and most realistic for that person.
Even when someone may be a good candidate, getting started is not always straightforward within traditional healthcare constraints. Insurance coverage can be limited, prior authorization is common, and some primary care providers may be less familiar, comfortable, or capable of managing obesity medication closely over time. That is part of what Cōr is designed to simplify: helping eligible patients navigate common barriers, access expert-guided treatment, and receive ongoing support throughout the process.
What to Know Before Starting a GLP-1
Starting a GLP-1 does not mean you will have an instant or dramatic response, and it does not mean the medication will work the same way for everyone. These treatments are not meant to replace nutrition, movement, or behavior support, and they are not a shortcut around the bigger picture of long-term weight and metabolic health. They are typically one part of a broader care plan, not a stand-alone solution. It also does not mean side effects are guaranteed, or that you should simply "push through" symptoms that feel severe or concerning. Some side effects are mild and improve over time, while others may be a sign that it is time to check in with your care team. GLP-1 medications also are not appropriate for everyone, including people who are pregnant or planning pregnancy, or those with certain contraindications that a clinician should review.
The most common side effects when starting a GLP-1 are gastrointestinal. Many people experience symptoms like nausea, diarrhea, vomiting, constipation, stomach discomfort, indigestion, bloating, or feeling overly full, especially early in treatment as the body adjusts. Fatigue, headache, dizziness, reflux, burping, and injection-site reactions can also happen in some patients. Because these medications can slow digestion, people may feel fuller sooner, which is part of how they work, but that same effect can also contribute to stomach-related symptoms during the adjustment period.
That is one reason support matters so much in the first few weeks. With Cōr, clients have a dedicated Advōcate for education, support, and care coordination throughout the process. That added layer of support can help clients feel less alone in the process and more confident about when to contact the clinical team with medical questions or concerning symptoms. The goal is to make sure patients feel informed, supported, and connected, while side effects, dosing decisions, and treatment changes remain with the licensed clinical team.
How Long Do People Usually Stay on a GLP-1 and What Happens If They Stop?
For many people, GLP-1 medications are not a short-term treatment. Current guidance increasingly treats them as a long-term option for obesity care when they are working, well tolerated, and medically appropriate. If a weight-management medication is helping and side effects are manageable, a clinician may advise continuing it long term. At the same time, if someone is not losing weight after 12 weeks on the full dose, that may prompt a clinician to reassess whether the medication is the right fit or whether the treatment plan should change.
That means there usually is not one "normal" timeline for how long someone stays on a GLP-1. Some people stay on treatment for many months or years, while others stop sooner because of side effects, cost, pregnancy, life changes, or because the medication is not helping enough. In practice, the right duration depends on how well the medication is working, how sustainable it feels, and whether the person and their clinician believe it still fits their long-term health plan.
It is also important for patients to know that coming off a GLP-1 can come with real changes. The best-known evidence comes from the STEP 1 extension study, which found that after stopping semaglutide, participants regained about two-thirds of the weight they had previously lost within one year, and some cardiometabolic improvements also moved back toward baseline. This does not mean everyone will have the exact same experience, but it does show that stopping treatment can bring back more hunger, less fullness, and gradual weight regain if there is not a thoughtful maintenance plan in place.
That is why the transition off a GLP-1 should ideally be treated as its own phase of care, not just the end of treatment. Patients may need help monitoring appetite changes, adjusting expectations, watching for weight regain, and understanding whether symptoms or setbacks are temporary or signs that the plan needs to change. Having a dedicated Cōr Advocate during that process can be extremely valuable.
An Advocate gives clients someone consistent to speak with as they come off medication, helping them stay connected to the care team and supported through the transition. That kind of support can make the transition feel less abrupt, less confusing, and more manageable over time, while decisions about dosing, symptoms, and treatment changes remain with the licensed clinical team.
Making an Informed, Supported Decision
GLP-1 medications have changed the conversation around weight loss and metabolic health, but deciding whether one may be right for you is about more than following a trend. Understanding what these medications are, how they work, the different options available, and what the experience of taking one may actually look like can help you make a more informed decision. For the right person, a GLP-1 can be a powerful tool, but like any treatment, it works best when it is thoughtfully matched to the individual and supported over time.
That is why guidance and ongoing support matter just as much as the medication itself. From choosing the right treatment to managing side effects, adjusting dosing, and navigating what happens over the long term, having expert support can make the process feel clearer and more sustainable. At Cōr, that support includes not only clinical oversight, but also a dedicated Advocate who can help patients feel informed, supported, and connected throughout the journey.
Sources
- National Institute of Diabetes and Digestive and Kidney Diseases – Prescription Medications to Treat Overweight and Obesity
- National Library of Medicine – GLP-1 Receptor Agonists in Obesity Management
- World Health Organization – Obesity and GLP-1 Therapies
- FDA – Semaglutide Prescribing Information
- KFF – Medicaid Coverage of and Spending on GLP-1s
- National Library of Medicine – Tirzepatide vs. Semaglutide: Comparative Outcomes
- JAMA – Weight Loss Outcomes with GLP-1 Receptor Agonists
- New England Journal of Medicine – STEP 1 Extension Study: Weight Regain After Semaglutide Discontinuation
- Mayo Clinic – Semaglutide (Subcutaneous Route)
Medical Disclaimer: The information in this article is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any new treatment. Services and medications may not be available in all states.
